In our previous studies, we showed that several PTPs, including DUSP9, PTPN9, and PTPN11, may be targeted to treat T2DM during their downregulation by increasing the phosphorylation of AMPK [21,22]. This evidence concerns the gene PTPN11 and type 2 diabetes mellitus.